Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Wullich

Showing results (61-70 of 251) with videos related to

Pageof 26
Sort By:
Life (Basel, Switzerland)|May 28, 2022
Reduced Recurrence Rates Are Associated with Photodynamic Diagnostics Compared to White Light after Extended Transurethral Resection of Bladder TumorsAlexander Marquardt, Mario Richterstetter, Helge Taubert, et al.
Annals of Surgical Oncology|October 31, 2012
Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladderBastian Keck, Sven Wach, Frank Kunath, et al.
Disease Markers|January 10, 2020
Molecular Composition of Genomic <i>TMPRSS2-ERG</i> Rearrangements in Prostate CancerManuela Krumbholz, Abbas Agaimy, Robert Stoehr, et al.
The Cochrane Database of Systematic Reviews|July 1, 2014
Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancerFrank Kunath, Henrik R Grobe, Gerta Rücker, et al.
Urologie (Heidelberg, Germany)|July 15, 2025
[Integration of complementary medicine in uro-oncology]Carolin C Hack, Katharina Seitz, Imke Thederan, et al.
Journal of Clinical Medicine|May 30, 2019
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell CarcinomaAndreas Kahlmeyer, Christine G Stöhr, Arndt Hartmann, et al.
European Urology|November 28, 2006
Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survivalJan Lehmann, Henrik Suttmann, Iva Kovac, et al.
Anticancer Research|April 19, 2011
15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatmentFrens Steffen Krause, Bernhard Walter, Oliver Josef Ott, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2009
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancerBarbara Seliger, Robert Stoehr, Diana Handke, et al.
European Journal of Radiology|November 9, 2024
Assessment of a fully-automated diagnostic AI software in prostate MRI: Clinical evaluation and histopathological correlationNadine Bayerl, Lisa C Adams, Alexander Cavallaro, et al.
Pageof 26

Showing results (61-70 of 251) with videos related to

Sort By:
Pageof 26
Life (Basel, Switzerland)|May 28, 2022
Reduced Recurrence Rates Are Associated with Photodynamic Diagnostics Compared to White Light after Extended Transurethral Resection of Bladder TumorsAlexander Marquardt, Mario Richterstetter, Helge Taubert, et al.
Annals of Surgical Oncology|October 31, 2012
Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladderBastian Keck, Sven Wach, Frank Kunath, et al.
Disease Markers|January 10, 2020
Molecular Composition of Genomic <i>TMPRSS2-ERG</i> Rearrangements in Prostate CancerManuela Krumbholz, Abbas Agaimy, Robert Stoehr, et al.
The Cochrane Database of Systematic Reviews|July 1, 2014
Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancerFrank Kunath, Henrik R Grobe, Gerta Rücker, et al.
Urologie (Heidelberg, Germany)|July 15, 2025
[Integration of complementary medicine in uro-oncology]Carolin C Hack, Katharina Seitz, Imke Thederan, et al.
Journal of Clinical Medicine|May 30, 2019
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell CarcinomaAndreas Kahlmeyer, Christine G Stöhr, Arndt Hartmann, et al.
European Urology|November 28, 2006
Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survivalJan Lehmann, Henrik Suttmann, Iva Kovac, et al.
Anticancer Research|April 19, 2011
15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatmentFrens Steffen Krause, Bernhard Walter, Oliver Josef Ott, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2009
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancerBarbara Seliger, Robert Stoehr, Diana Handke, et al.
European Journal of Radiology|November 9, 2024
Assessment of a fully-automated diagnostic AI software in prostate MRI: Clinical evaluation and histopathological correlationNadine Bayerl, Lisa C Adams, Alexander Cavallaro, et al.
Pageof 26